FANCB Antibody, HRP conjugated

Code CSB-PA818751LB01HU
Size US$166
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) FANCB Polyclonal antibody
Uniprot No.
Target Names
FANCB
Alternative Names
FA2 antibody; FAAP90 antibody; FAAP95 antibody; FAB antibody; FACB antibody; Fancb antibody; FANCB_HUMAN antibody; Fanconi anemia associated polypeptide of 95 kDa antibody; Fanconi anemia group B protein antibody; Fanconi anemia; complementation group B antibody; Fanconi anemia-associated polypeptide of 95 kDa antibody; Protein FACB antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human Fanconi anemia group B protein (431-574AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
HRP
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Tested Applications
ELISA
Protocols
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Usage
For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
DNA repair protein required for FANCD2 ubiquitination.
Gene References into Functions
  1. We identified a 9154 bp intragenic duplication in FANCB, covering the first coding exon 3 and the flanking regions. The duplicated allele gives rise to an aberrant transcript containing exon 3 duplication, predicted to introduce a stop codon in FANCB protein (p.A319*). PMID: 29193904
  2. Four single nucleotide polymorphisms were identified, three of which were located in untranslated regions of Fanconi anemia group B protein (FANCB) and predicted to be associated with normal function. PMID: 29491055
  3. Loss-of-function FANCB mutations result in a recognizable, multiple malformation phenotype in hemizygous males for which we propose clinical criteria to aid diagnosis. PMID: 21910217
  4. Inactivation of FancB may play a role in the pathogenesis of sporadic HNSCC. PMID: 20332657
  5. Elevated serum FA-2 was associated with bony metastases from breast cancer. PMID: 20465790
  6. the protein defective in individuals with Fanconi anemia belonging to complementation group B is an essential component of the nuclear protein 'core complex' responsible for monoubiquitination of FANCD2 PMID: 15502827
  7. summary of recent advances in the Fanconi anemia-BRCA network with emphasis on the new discovery of FAAP95 as the true FANCB gene [review] PMID: 15611632
  8. Mutations in FANCB are a cause of X linked VACTERL-H syndrome. PMID: 16679491
  9. Mus81 and FANCB have different roles in repair of DNA damage during replication in human cells PMID: 17903171
  10. Our results rule out a major contribution of FANCB to hereditary breast cancer. PMID: 18302019

Show More

Hide All

Involvement in disease
Fanconi anemia complementation group B (FANCB)
Subcellular Location
Nucleus.
Database Links

HGNC: 3583

OMIM: 300514

KEGG: hsa:2187

STRING: 9606.ENSP00000326819

UniGene: Hs.554740

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*